Skip to main content
Toggle navigation
Login
Home
Back
Favorite
0
Like
Facebook
Tweet
Session V: Emerging Concepts in Urothelial Cancer
Debate: Optimal End Points in Clinical Trials: Disease-Free Survival (DFS) vs Overall Survival (OS) - OS
Thursday, March 10, 2022
9:37 AM – 9:44 AM
Debate Speaker(s)
Andrea B. Apolo, MD
Bethesda, MD